Country
City
Lörrach
EastPharma Ltd was founded in 2006 with the goal of establishing a significant presence in the rapidly expanding pharmaceutical industry of developing markets through organic growth, acquisitions, and market consolidation. Following the acquisition of the Turkish generic pharmaceutical company DEVA in 2006 and Saba in 2007 through its subsidiary East Pharma Sarl, EastPharma Ltd has applied seasoned management expertise to ensure the strong position and enhanced market share and profitability of these acquired companies. EastPharma Ltd was a publicly traded company on the London Stock Exchange (LSE) from 2008 until it was removed from the listings on August 1st, 2019.